GTM Playbook for Cardiology Practices in 2027

The revenue problem private cardiology is actually solving

Most independent Cardiology owners think they run a clinical business. They actually run a referral-and-ancillary business that happens to practice medicine, and the practices that miss this leak revenue in three predictable places. First, roughly 78% of first visits arrive through a PCP, an ED discharge, or an in-network specialist — only about 22% self-search — so a practice with weak referral relationships is starving its funnel no matter how good its Google Ads look. Second, the professional fee is a trap. Reading a complete transthoracic echo pays a professional-only fee of roughly $45-$70, while owning the equipment and billing the global (technical + professional) fee pays $220-$320 per study on CPT 93306. A practice that reads on hospital equipment instead of owning its own echo line is voluntarily giving up three-quarters of the collectible revenue on its single highest-volume test.

Third, payor mix drift quietly caps the ceiling. Medicaid pays only 62-71% of the Medicare rate for most cardiology codes, so a practice that lets Medicaid creep past 8-10% of volume is trading high-margin slots for low-margin ones it can never re-price. The compounding failure is that these three leaks reinforce each other: thin referrals mean low volume, low volume means the ancillary equipment never reaches breakeven, and an unbalanced payor mix means even the volume you do capture underpays. The whole Playbook exists to close all three simultaneously — build the referral moat, own the technical component, and defend the payor mix — because fixing only one of the three does not move per-physician collections enough to matter.

Root-cause map: where cardiology revenue is won or lost

The patient journey is the revenue map. Every cardiology dollar traces back to how a patient entered, how fast they were seen, which workup path they took, and whether they became a 20-year annuity relationship rather than a one-visit consult. Mapping it end to end shows exactly which nodes a new owner must instrument, because a bottleneck at intake (slow access) or at the workup fork (referring the echo out instead of doing it in-house) severs the revenue downstream of it.

Read the map as a set of failure points. If access slips past a 3-day new-patient window (national average is 14-26 days), PCPs quietly reroute referrals and the top of the funnel collapses. If the workup fork sends echo, nuclear, and CCTA studies to a hospital instead of an owned ancillary line, the practice keeps only the ~$58 professional fee and hands the ~$200 technical component to someone else. And if the annuity nodes — annual echo, device checks, chronic care management — are never templated into the EHR, the practice re-acquires patients it already owned. The map is the diagnostic: every leak in the revenue problem above corresponds to a specific node here.

Benchmarks and ranges every owner should underwrite to

Underwrite the Playbook to real MedAxiom and MGMA-blended benchmarks, not to hope. At median productivity (~7,800 wRVUs), a general/non-invasive cardiologist earns $650K-$725K total compensation; invasive non-interventional runs $774K-$826K; interventional $750K-$895K plus a $30K-$50K cath-lab medical-director stipend; and electrophysiologists command $798K-$985K — the highest-leverage hire if you have AFib volume. Collections per FTE physician land at $4.1M-$6.5M, and top-quartile practices run 1.8-2.4 advanced practice providers per cardiologist to protect that number, because APPs absorb routine follow-ups at $148K-$182K base while the MD stays on complex, high-wRVU work.

The reimbursement ranges that drive the ancillary decision, against the 2026 CMS conversion factor of $33.40: 93306 complete TTE pays ~$245 global vs ~$58 professional; 93458 left-heart cath/coronary angio pays $3,100-$3,800 in the hospital outpatient setting, $2,400-$2,900 in an ASC, ~$390 professional; 92928 single-vessel PCI with stent pays $8,400-$11,200 global, ~$680 professional; 93880 carotid duplex ~$210 global; and 75574 CCTA with quantitative eval pays ~$430-$510 global, with commercial coverage now near-universal after the 2025 ACC/AHA chest-pain guideline update.

Ancillary CapEx and breakeven set the build order. In-office echo on a used GE Vivid E95 runs $95K-$135K and breaks even at ~9 studies/week. Nuclear SPECT MPI runs $425K-$650K plus a camera-room buildout, breaks even at 14-18 studies/week, and requires an NRC license and a radiation safety officer. CCTA is best rented first — read on a hospital scanner under a professional-component arrangement at $85-$110 per read — before committing $1.9M-$2.6M to a 256-slice scanner. An office-based lab for diagnostic cath is a $1.8M-$3.2M buildout that needs a 2,000+ qualifying-cath/year pipeline; the CY2026 OBL site-of-service bump of +6.1% is what keeps its economics attractive. Target payor mix: 52-58% Medicare FFS plus Advantage, 30-36% commercial, 4-8% Medicaid (capped), 1-3% cash — and price calcium scores at $99-$149 cash because they convert to downstream CCTA.

Trade-offs and alternatives the Playbook forces you to choose

Every lever in this Playbook is a real trade-off, not a free win, and the alternative to building it is usually selling to private equity. Own vs. refer ancillaries is the first fork. Buying a nuclear camera captures the full technical component but locks up $425K-$650K, adds NRC compliance overhead, and only pays off above 14-18 studies/week — so a low-volume solo practice is often better renting reads until referral volume justifies the capital. In-house vs. outsourced RCM is the second: in-house billing runs 3.8-4.6% of net collections and keeps control, while outsourced partners charge 5.5-7.5% but frequently recover an extra 2-4 points on denials for a new owner still learning cardiology-specific coding — the higher fee is worth it in year one and often not by year three.

EHR tier trades cost against denial performance. AdvancedMD or eClinicalWorks at ~$429-$449/provider/month go live in ~4 weeks and fit 1-3 cardiologists; athenaOne at 4-7% of collections wins on a ~3.2% denial-rate floor versus an 8.1% industry norm but takes 10-12 weeks to implement; NextGen Enterprise or Epic Community Connect only make sense at 10+ providers or in a hospital JV. The largest strategic trade-off is PE platform vs. independent partnership track. Platforms like CVUSA, US Cardiology Partners, US Heart & Vascular, and Cardiovascular Logistics recruit with $200K-$450K signing bonuses, equity rollover, and 5-year MSAs that a solo owner cannot match on cash. The independent counter-offer is structural, not financial: a real 2-year associate to year-3 buy-in at 1.0-1.4x trailing EBITDA share with pro-rata ancillary distributions — the one thing PE cannot replicate, because PE keeps the ancillary margin for its investors. A practice with no written partnership track by an associate's year three will lose that hire, and losing hires in an 11,000-14,000-cardiologist projected 2030 shortage is how independents get consolidated.

Rollout plan: the first 90 days as owner

Sequence matters because credentialing and licensing run on 60-95 day clocks that gate revenue, so they start on day one even though they pay off in month three. The rollout below front-loads the slow, external dependencies (payor credentialing, NRC license, EHR go-live) while building referral and echo volume in parallel.

In days 0-30, sign EHR and RCM contracts, start Medicare/Medicaid credentialing immediately (65-95 day clock), hire a physician liaison plus two front-desk and one MA per cardiologist, lock the echo purchase or lease, and build a PCP target list of 75-120 offices within a 15-mile radius. In days 31-60, run the PCP tour at 15-20 offices/week, launch the Google Business Profile with a 200-review push, stand up the echo lab toward 40 studies/week, file the NRC nuclear license, and push commercial fee schedules to 115-128% of Medicare on E&M and 125-145% on procedural codes. In days 61-90, add the nuclear stress line (8/week by day 90, 15 by day 120), onboard a remote CIED monitoring contract, run the first coding audit (often free with the RCM partner), hit and publish the 3-day new-patient access SLA to the PCP network, and open the first partner-track conversation with associate hires. Instrument referral-to-visit lag weekly in the EHR from day one — it is the earliest warning that the funnel is drifting.

Related questions

How many referring PCPs does one cardiologist need?

Lock in 12-18 primary-care physicians as consistent referral sources per cardiologist. That range sustains a steady pipeline without over-relying on any single relationship, and it is the highest-ROI activity a new owner can run before spending a dollar on paid acquisition.

What ancillary service should a new owner build first?

In-office echocardiography. On a used GE Vivid E95 at $95K-$135K it breaks even near 9 studies/week — the fastest ancillary to profitability. Nuclear stress, CCTA, and an office-based cath lab follow only once referral volume clears their higher breakeven thresholds.

How do independents compete with private equity for hires?

Not on cash — PE offers $200K-$450K signing bonuses independents cannot match. Compete on structure: a written year-3 partnership buy-in at 1.0-1.4x trailing EBITDA share with pro-rata ancillary distributions, the one economic lever PE keeps for investors and structurally cannot offer a new associate.

Which payor mix keeps a practice sustainable?

Target 52-58% Medicare, 30-36% commercial, 4-8% Medicaid (capped, since it pays 62-71% of Medicare), and 1-3% cash. Recalibrate fee schedules quarterly; annual-only updates leave 5-10% of collectible revenue unclaimed as contracts and CMS rates shift.

FAQ

How many referring PCPs does a cardiologist typically need in 2027? A well-performing cardiologist should lock in 12 to 18 primary-care physicians as consistent referral sources. This range supports a steady patient pipeline without overloading any single PCP relationship, and it is defended by a 3-day access window and 24-hour read turnaround.

What ancillary services boost cardiology revenue the most? Echocardiography, nuclear stress testing, coronary CT angiography (CCTA), and an in-office catheterization lab can lift technical-component revenue 30% to 45% above practices billing professional fees only. The right mix depends on local reimbursement rates and whether referral volume clears each service's breakeven.

What is the typical payor mix for a successful private cardiology practice? Roughly 65% to 72% combined Medicare and commercial insurance, with the remainder from Medicaid, self-pay, or other plans. Medicaid should stay capped near 4-8% because it pays only 62-71% of the Medicare rate for cardiology codes. Recalibrate fee schedules quarterly.

What are realistic compensation and collections benchmarks? Median cardiologist compensation runs $588,000 to $826,000 annually depending on subspecialty, with collections per full-time-equivalent physician of $4.1 million to $6.5 million. These figures track industry benchmarks such as MedAxiom and MGMA and assume median productivity near 7,800 wRVUs.

How many advanced practice providers should support each cardiologist? Top-quartile practices run 1.8 to 2.4 APPs per cardiologist. This ratio lets the physician concentrate on complex, high-wRVU cases while NPs and PAs handle routine follow-ups, chronic care management, and preventive visits — the leverage that protects per-physician collections.

How often should a cardiology practice update its fee schedules? At least quarterly, to reflect changes in Medicare, commercial contracts, and local market rates. Relying on annual updates alone risks leaving 5% to 10% of potential revenue uncollected as CMS conversion factors and commercial contract terms shift through the year.

Sources

• MedAxiom 2024 Cardiovascular Provider Compensation and Production Survey
• MGMA DataDive Provider Compensation Data
• Cardiovascular Business — Cardiologist compensation hits an all-time high
• CMS Physician Fee Schedule
• SCAI Guide to Billing, Coding, and Reimbursement for Interventional Cardiology
• Becker's Cardiology — Cardiology and private equity in 2026
• JAMA Health Forum — Trends in Private Equity Consolidation in Cardiovascular Care
• CardioOne — Digital-First Growth Strategy for Independent Cardiologists
• Cardiovascular Associates of America — About CVAUSA

Related on PULSE

• [GTM Playbook for Concierge Medicine Practices in 2027](/knowledge/gp0368)
• [GTM Playbook for Dermatology Practices in 2027](/knowledge/gp0348)
• [GTM Playbook for Pediatric Practices in 2027](/knowledge/gp0349)
• [GTM Playbook for OB-GYN Practices in 2027](/knowledge/gp0350)
• [GTM Playbook for Functional Medicine Practices in 2027](/knowledge/gp0346)
• [GTM Playbook for Bookkeeping and Tax Prep Practices in 2027](/knowledge/gp0332)